Manuel Ritter

6PUBLICATIONS
92CO-AUTHORS
Predictive and prognostic markersMolecular targetsEmergency medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 09, 2026
Integrating NECTIN4 Amplification With Membranous Nectin-4 Expression to Develop a Scoring System for Predicting Enfortumab Vedotin Response in Urothelial Carcinoma.

|Apr 24, 2024
NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer.

Niklas Klümper, Ngoc Khanh Tran, Stefanie Zschäbitz

|Jan 04, 2024
Adipocyte Precursor-Derived NRG1 Promotes Resistance to FGFR Inhibition in Urothelial Carcinoma.

Sana Hosni, Viola Kilian, Niklas Klümper

|Feb 22, 2023
Ethical challenges in the prioritization of elective care in pandemic settings: On the significance of time-sensitive scoring.

Sarah Diner, Manuel Ritter, Mariacarla Gadebusch Bondio

|Dec 19, 2022
Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance.

Niklas Klümper, Damian J Ralser, Jörg Ellinger

|Oct 27, 2021
Impact of COVID-19 on gynaecological patient care: results of patient's survey with 327 patients.

F Recker, S Dohmen, E K Egger

Pageof 1

Frequent Collaborators

4 joint publications

Marieta Toma

4 joint publications

Oliver Hahn

4 joint publications

Michael Hölzel

4 joint publications

Niklas Klümper